In a column, Mr. Gingrich said Congress should ban exclusivity agreements between device makers and medical providers making their agreed-upon prices confidential. This makes “true price competition in the $153 billion medical-device marketplace impossible” and prices can be marked up “hundreds of percentage points,” Mr. Gingrich said.
He cited a 2009 report from McKinsey Global Institute showing hip implants cost 60 percent more in the United States than in several major European countries. In 2007, however, Congress failed to pass a bill that would have required implantable device makers to report sales data to the government.
Read the DOTmed report on medical devices.
Related Articles on Medical Devices:
5 Tips for Lowering Implant Costs at Orthopedic Surgery Centers
Device Makers’ Confidentiality Will Raise Costs, AHRMM Says
ETHOS Founder: Don’t Be Easily Allured by Medical Technology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.